chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash, Rash erythematous
Clinical narrative: back of my ear has rash and is very red; sometimes a little pain; rash in the back of my right ear; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash in the back of my right ear), RASH ERYTHEMATOUS (back of my ear has rash and is very red) and PAIN (sometimes a little pain) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced RASH (rash in the back of my right ear). On an unknown date, the patient experienced RASH ERYTHEMATOUS (back of my ear has rash and is very red) and PAIN (sometimes a little pain). At the time of the report, RASH (rash in the back of my right ear) had not resolved and RASH ERYTHEMATOUS (back of my ear has rash and is very red) and PAIN (sometimes a little pain) outcome was unknown.            No concomitant medications were reported. No treatment medication were reported.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Severe chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Severe chills) and PYREXIA (fever) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (COVID in april). Concurrent medical conditions included Asthma.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 5 milliliter. On 03-Aug-2021, the patient experienced CHILLS (Severe chills) and PYREXIA (fever). At the time of the report, CHILLS (Severe chills) and PYREXIA (fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Heavy menstrual bleeding, Mood altered, Premenstrual syndrome
Clinical narrative: Severe cramping; Mood changes; Premenstrual syndrome; Mensuration changes; This spontaneous case was reported by a pharmacist and describes the occurrence of HEAVY MENSTRUAL BLEEDING (Mensuration changes), DYSMENORRHOEA (Severe cramping), MOOD ALTERED (Mood changes) and PREMENSTRUAL SYNDROME (Premenstrual syndrome) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 083c21a) for COVID-19 vaccination.     The patient's past medical history included Bleeding and C-section. Concurrent medical conditions included Drug allergy (fexofenadine). Concomitant products included IBUPROFEN, PHENTERMINE, DULOXETINE, MONTELUKAST SODIUM (SINGULAIR) and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for an unknown indication.   On 23-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 04-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 23-May-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (Mensuration changes). On an unknown date, the patient experienced DYSMENORRHOEA (Severe cramping), MOOD ALTERED (Mood changes) and PREMENSTRUAL SYNDROME (Premenstrual syndrome). At the time of the report, HEAVY MENSTRUAL BLEEDING (Mensuration changes), DYSMENORRHOEA (Severe cramping), MOOD ALTERED (Mood changes) and PREMENSTRUAL SYNDROME (Premenstrual syndrome) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information does not provided.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Rash
Clinical narrative: Shingles; Rashes; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles) and RASH (Rashes) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Allergy to molds, Dust allergy (Dust mites), Allergy to animals (allergy to cats), Allergy to animals (Allergy to dogs), Pollen allergy and Seasonal allergy.   On 26-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced HERPES ZOSTER (Shingles) and RASH (Rashes). At the time of the report, HERPES ZOSTER (Shingles) and RASH (Rashes) had not resolved.            Patient reported to allergy to mildew.  No concomitant medications were reported. no treatment medications were reported.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Nasal congestion, Pyrexia, Secretion discharge
Clinical narrative: Extreme mucous; Throwing up; Fever; Chills; Congestion; Coughing; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Congestion), COUGH (Coughing), SECRETION DISCHARGE (Extreme mucous), PYREXIA (Fever) and CHILLS (Chills) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fish allergy (Fish allergy).    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient experienced NASAL CONGESTION (Congestion), COUGH (Coughing), PYREXIA (Fever) and CHILLS (Chills). On an unknown date, the patient experienced SECRETION DISCHARGE (Extreme mucous) and VOMITING (Throwing up). On 04-Aug-2021, NASAL CONGESTION (Congestion), COUGH (Coughing), PYREXIA (Fever) and CHILLS (Chills) had not resolved. At the time of the report, SECRETION DISCHARGE (Extreme mucous) and VOMITING (Throwing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by the reporter. Treatment information was not provided.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Extreme mucous; Throwing up; Fever; Chills; Congestion; Coughing; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Congestion), COUGH (Coughing), SECRETION DISCHARGE (Extreme mucous), PYREXIA (Fever) and CHILLS (Chills) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fish allergy (Fish allergy).    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Aug-2021, the patient experienced NASAL CONGESTION (Congestion), COUGH (Coughing), PYREXIA (Fever) and CHILLS (Chills). On an unknown date, the patient experienced SECRETION DISCHARGE (Extreme mucous) and VOMITING (Throwing up). On 04-Aug-2021, NASAL CONGESTION (Congestion), COUGH (Coughing), PYREXIA (Fever) and CHILLS (Chills) had not resolved. At the time of the report, SECRETION DISCHARGE (Extreme mucous) and VOMITING (Throwing up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by the reporter. Treatment information was not provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Pain
Clinical narrative: Severe nerve pain in left hip and left lower abdomen.; Felt like deep burning pain; This spontaneous case was reported by an other health care professional and describes the occurrence of NEURALGIA (Severe nerve pain in left hip and left lower abdomen.) and PAIN (Felt like deep burning pain) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     Concurrent medical conditions included Cytogenetic abnormality (genetic deletions 15q11.21, 16p, 2p16.3 found when son was diagnosed with autism).    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021, the patient experienced NEURALGIA (Severe nerve pain in left hip and left lower abdomen.) and PAIN (Felt like deep burning pain). At the time of the report, NEURALGIA (Severe nerve pain in left hip and left lower abdomen.) and PAIN (Felt like deep burning pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication use was reported.  No treatment information was reported.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Myalgia, Vaccination site movement impairment, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Severe diarrhea), VACCINATION SITE MOVEMENT IMPAIRMENT (I cant lift my arm over my head), VACCINATION SITE WARMTH (Its hot to the touch), VACCINATION SITE SWELLING (Injection site swelling) and MYALGIA (Muscle ache) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Asthma. On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Severe diarrhea), VACCINATION SITE MOVEMENT IMPAIRMENT (I cant lift my arm over my head), VACCINATION SITE WARMTH (Its hot to the touch), VACCINATION SITE SWELLING (Injection site swelling), MYALGIA (Muscle ache), VACCINATION SITE PAIN (Injection site pain/ severe pain/ Burning/Can't touch the injection site/ It hurts to bad) and HEADACHE (Headache). At the time of the report, DIARRHOEA (Severe diarrhea), VACCINATION SITE MOVEMENT IMPAIRMENT (I cant lift my arm over my head), VACCINATION SITE SWELLING (Injection site swelling), MYALGIA (Muscle ache), VACCINATION SITE PAIN (Injection site pain/ severe pain/ Burning/Can't touch the injection site/ It hurts to bad) and HEADACHE (Headache) had not resolved and VACCINATION SITE WARMTH (Its hot to the touch) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant Medications details were provided. No Treatment Medications details were provided.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Severe diarrhea), VACCINATION SITE MOVEMENT IMPAIRMENT (I cant lift my arm over my head), VACCINATION SITE WARMTH (Its hot to the touch), VACCINATION SITE SWELLING (Injection site swelling) and MYALGIA (Muscle ache) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Asthma. On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Severe diarrhea), VACCINATION SITE MOVEMENT IMPAIRMENT (I cant lift my arm over my head), VACCINATION SITE WARMTH (Its hot to the touch), VACCINATION SITE SWELLING (Injection site swelling), MYALGIA (Muscle ache), VACCINATION SITE PAIN (Injection site pain/ severe pain/ Burning/Can't touch the injection site/ It hurts to bad) and HEADACHE (Headache). At the time of the report, DIARRHOEA (Severe diarrhea), VACCINATION SITE MOVEMENT IMPAIRMENT (I cant lift my arm over my head), VACCINATION SITE SWELLING (Injection site swelling), MYALGIA (Muscle ache), VACCINATION SITE PAIN (Injection site pain/ severe pain/ Burning/Can't touch the injection site/ It hurts to bad) and HEADACHE (Headache) had not resolved and VACCINATION SITE WARMTH (Its hot to the touch) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant Medications details were provided. No Treatment Medications details were provided.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia oral
Clinical narrative: tingling front of tongue and lips; Numbness front of tongue and lips; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (tingling front of tongue and lips) and HYPOAESTHESIA ORAL (Numbness front of tongue and lips) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Pollen allergy and Asthma (allergy induced Asthma).   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced PARAESTHESIA ORAL (tingling front of tongue and lips) and HYPOAESTHESIA ORAL (Numbness front of tongue and lips). On 05-Mar-2021, PARAESTHESIA ORAL (tingling front of tongue and lips) and HYPOAESTHESIA ORAL (Numbness front of tongue and lips) had resolved.            Patient reported that she takes allergy shots for pollen allergy.  No treatment information was provided.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Patient started their bowel movements early in the morning it slowed down and then late afternoon; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Patient started their bowel movements early in the morning it slowed down and then late afternoon) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Aug-2021, the patient experienced DIARRHOEA (Patient started their bowel movements early in the morning it slowed down and then late afternoon). On 06-Aug-2021, DIARRHOEA (Patient started their bowel movements early in the morning it slowed down and then late afternoon) had not resolved.            No concomitant medication information was provided by the reporter.  The patient started their bowel movements early in the morning, then it slowed down and started again in the late afternoon.  No treatment information was provided by the reporter.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Tachycardia
Clinical narrative: Rapid heart rate; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Rapid heart rate) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced TACHYCARDIA (Rapid heart rate). On 02-Apr-2021, TACHYCARDIA (Rapid heart rate) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Apr-2021, Heart rate: rapid (abnormal) Rapid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant Medications were reported. No treatment information was provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Fever, Chill, whole body aches; Fever, Chill, whole body aches; Fever, Chill, whole body aches; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever, Chill, whole body aches), CHILLS (Fever, Chill, whole body aches) and MYALGIA (Fever, Chill, whole body aches) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Aug-2021, the patient experienced PYREXIA (Fever, Chill, whole body aches), CHILLS (Fever, Chill, whole body aches) and MYALGIA (Fever, Chill, whole body aches). On 11-Aug-2021, PYREXIA (Fever, Chill, whole body aches), CHILLS (Fever, Chill, whole body aches) and MYALGIA (Fever, Chill, whole body aches) had resolved. Not Provided          No concomitant medications were reported.  No treatment information was reported.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Feeling abnormal
Clinical narrative: brain fog; chest pain (upper, left side); This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain (upper, left side)) and FEELING ABNORMAL (brain fog) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Aug-2021, the patient experienced CHEST PAIN (chest pain (upper, left side)) and FEELING ABNORMAL (brain fog). At the time of the report, CHEST PAIN (chest pain (upper, left side)) and FEELING ABNORMAL (brain fog) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered CHEST PAIN (chest pain (upper, left side)) and FEELING ABNORMAL (brain fog) to be possibly related.    No concomitant medication information was reported. No treatment medication information was reported. This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain (upper, left side)) and FEELING ABNORMAL (brain fog) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Aug-2021, the patient experienced CHEST PAIN (chest pain (upper, left side)). On 12-Aug-2021, the patient experienced FEELING ABNORMAL (brain fog). At the time of the report, CHEST PAIN (chest pain (upper, left side)) and FEELING ABNORMAL (brain fog) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered CHEST PAIN (chest pain (upper, left side)) and FEELING ABNORMAL (brain fog) to be possibly related.    No concomitant medication information was reported. No treatment medication information was reported.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Dry skin, Eczema, Erythema, Feeling abnormal, Insomnia
Clinical narrative: This spontaneous case was reported by a non-health professional and describes the occurrence of ECZEMA (Rash - Eczema Flair up), PRURITUS (Itchiness), DRY SKIN (extreme dryness of skin), SCAR (splitting of skin) and RASH MACULAR (Blotchy patches covering the body) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Anemia and High cholesterol since an unknown date. Concurrent medical conditions included Hypertension. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced ECZEMA (Rash - Eczema Flair up). On an unknown date, the patient experienced PRURITUS (Itchiness), DRY SKIN (extreme dryness of skin), SCAR (splitting of skin), RASH MACULAR (Blotchy patches covering the body), SKIN EXFOLIATION (scaling of skin), SCAB (1/4 inch scabs covering the bottom of feet), SKIN DISCOLOURATION (skin discoloration), SKIN EXFOLIATION (flaking skin), FEELING ABNORMAL (lessoning of feeling of touch), INSOMNIA (sleep loss), SWELLING (Swelling of hands and feet) and ERYTHEMA (redness of skin). On 26-Aug-2021, ECZEMA (Rash - Eczema Flair up) had resolved. At the time of the report, PRURITUS (Itchiness), DRY SKIN (extreme dryness of skin), SCAR (splitting of skin), RASH MACULAR (Blotchy patches covering the body), SKIN EXFOLIATION (scaling of skin), SCAB (1/4 inch scabs covering the bottom of feet), SKIN DISCOLOURATION (skin discoloration), SKIN EXFOLIATION (flaking skin), FEELING ABNORMAL (lessoning of feeling of touch), INSOMNIA (sleep loss), SWELLING (Swelling of hands and feet) and ERYTHEMA (redness of skin) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Concomitant medications were reported. No Treatment information was reported.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash macular, Scab, Scar, Skin discolouration
Clinical narrative: This spontaneous case was reported by a non-health professional and describes the occurrence of ECZEMA (Rash - Eczema Flair up), PRURITUS (Itchiness), DRY SKIN (extreme dryness of skin), SCAR (splitting of skin) and RASH MACULAR (Blotchy patches covering the body) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Anemia and High cholesterol since an unknown date. Concurrent medical conditions included Hypertension. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced ECZEMA (Rash - Eczema Flair up). On an unknown date, the patient experienced PRURITUS (Itchiness), DRY SKIN (extreme dryness of skin), SCAR (splitting of skin), RASH MACULAR (Blotchy patches covering the body), SKIN EXFOLIATION (scaling of skin), SCAB (1/4 inch scabs covering the bottom of feet), SKIN DISCOLOURATION (skin discoloration), SKIN EXFOLIATION (flaking skin), FEELING ABNORMAL (lessoning of feeling of touch), INSOMNIA (sleep loss), SWELLING (Swelling of hands and feet) and ERYTHEMA (redness of skin). On 26-Aug-2021, ECZEMA (Rash - Eczema Flair up) had resolved. At the time of the report, PRURITUS (Itchiness), DRY SKIN (extreme dryness of skin), SCAR (splitting of skin), RASH MACULAR (Blotchy patches covering the body), SKIN EXFOLIATION (scaling of skin), SCAB (1/4 inch scabs covering the bottom of feet), SKIN DISCOLOURATION (skin discoloration), SKIN EXFOLIATION (flaking skin), FEELING ABNORMAL (lessoning of feeling of touch), INSOMNIA (sleep loss), SWELLING (Swelling of hands and feet) and ERYTHEMA (redness of skin) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Concomitant medications were reported. No Treatment information was reported.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Skin exfoliation, Swelling
Clinical narrative: This spontaneous case was reported by a non-health professional and describes the occurrence of ECZEMA (Rash - Eczema Flair up), PRURITUS (Itchiness), DRY SKIN (extreme dryness of skin), SCAR (splitting of skin) and RASH MACULAR (Blotchy patches covering the body) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Anemia and High cholesterol since an unknown date. Concurrent medical conditions included Hypertension. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced ECZEMA (Rash - Eczema Flair up). On an unknown date, the patient experienced PRURITUS (Itchiness), DRY SKIN (extreme dryness of skin), SCAR (splitting of skin), RASH MACULAR (Blotchy patches covering the body), SKIN EXFOLIATION (scaling of skin), SCAB (1/4 inch scabs covering the bottom of feet), SKIN DISCOLOURATION (skin discoloration), SKIN EXFOLIATION (flaking skin), FEELING ABNORMAL (lessoning of feeling of touch), INSOMNIA (sleep loss), SWELLING (Swelling of hands and feet) and ERYTHEMA (redness of skin). On 26-Aug-2021, ECZEMA (Rash - Eczema Flair up) had resolved. At the time of the report, PRURITUS (Itchiness), DRY SKIN (extreme dryness of skin), SCAR (splitting of skin), RASH MACULAR (Blotchy patches covering the body), SKIN EXFOLIATION (scaling of skin), SCAB (1/4 inch scabs covering the bottom of feet), SKIN DISCOLOURATION (skin discoloration), SKIN EXFOLIATION (flaking skin), FEELING ABNORMAL (lessoning of feeling of touch), INSOMNIA (sleep loss), SWELLING (Swelling of hands and feet) and ERYTHEMA (redness of skin) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Concomitant medications were reported. No Treatment information was reported.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Tachycardia
Clinical narrative: shortness of breath, rapid heart beat; shortness of breath, rapid heart beat; This spontaneous case was reported by an other health care professional and describes the occurrence of DYSPNOEA (shortness of breath, rapid heart beat) and TACHYCARDIA (shortness of breath, rapid heart beat) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017EZ1A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma, Drug allergy (allergic to ibuprofen.) and Drug allergy (allergic to aspirin.).    On 26-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Aug-2021, the patient experienced DYSPNOEA (shortness of breath, rapid heart beat) and TACHYCARDIA (shortness of breath, rapid heart beat). On 27-Aug-2021, DYSPNOEA (shortness of breath, rapid heart beat) and TACHYCARDIA (shortness of breath, rapid heart beat) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication was not provided by the reporter.  Treatment medication included albuterol puff and benadry.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted to inpatient facility with covid infection
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted to inpatient facility with covid infection
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure during pregnancy, SARS-CoV-2 test positive
Clinical narrative: Pt admitted with covid infection
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Error: Booster given too early.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted with covid infection
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted with covid infection
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Sensitive skin, Swelling
Clinical narrative: Systemic: Lymph Node Swelling-Medium, Additional Details: Patient is stating that between his armpit and chest on his body is swollen and sensitive.  It is not painful.  It is sensitive when he raises his arm. I asked him where shot was given and he showed me over his clothes.  It looked like it was given in the appropriate spot from what he showed me.  I asked him if he thought it was given in an unusual spot and he stated that he did not think so.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted with covid infection
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrough  dose 1 Moderna 4/7/21  008B212A dose 2 Moderna 5/5/21  043B21A
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Numbness in pinky and ring finger on left hand
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase normal, Albumin globulin ratio, Anti-thyroid antibody, Antibody test positive, Antinuclear antibody
Clinical narrative: I initially experienced severe body aches, a headache, and a fever with the initial dosage given on March 2, 2021 at the same location noted above (Lot 027A21A).  Following the shot on March 31, 2021, symptoms began on April 1, 2021 at 3:00 a.m.  I experienced more severe body aches, a fever of 102.5 degrees F, chills, a severe headache and severe dizziness.  The fever, chills, and severe headache subsided within 24-36 hours, with intermittent residual low grade fevers and dizziness for the next 3-5 days.  I also experienced what I would refer to as "brain fog" in that I felt like I was struggling to do certain tasks or concentrate.  Within two weeks of the second dosage, I noticed that I was experiencing joint pain throughout my body, even in joints that I never injured or had problems with in the past.  For three months, I was suffering from cyclical bouts of joint pain.  The pain was also accompanied with a low grade fever (between 100.5 and 101.5 degrees F).  The joint pain would last, but the fevers would subside within 24 hours.  These symptoms lasted through July 2021.  Eventually the fevers stopped, but the joint pain became progressively worse.  I sought medical attention with a Rheumatologist in September 2021.   I responded initially to an oral steroid.  OTC pain and/or anti-inflammatory medications did not work or reduce inflammation.  I had blood and urine testing as noted in section 19.  Dr. also prescribed Sulfasalazine, but I did not have any symptomatic improvement.  I'm currenlty on another round of oral steroids and I recently started Hydroxychloroquine.  Most of my labs were normal; however, my ANA Titer was 1:1280 and I recently tested positive for with a 1.8 for Chromatin Antibody.  Dr. has diagnosed me with Undifferentiated Connective Tissue Disease.  My lab work is consistant with Lupus, but my symptoms are more indicative of Rhematory Arthritis.   It is imporant to note that on September 22, 2021, my Chromatin Antibody test came back normal.  However, I was retested on January 31, 2022 and tested positive.  My ANA Titer was unchanged.    *See page 2 for continuation*
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Antinuclear antibody increased, Antinuclear antibody negative, Antiribosomal P antibody, Arthralgia, Aspartate aminotransferase normal
Clinical narrative: I initially experienced severe body aches, a headache, and a fever with the initial dosage given on March 2, 2021 at the same location noted above (Lot 027A21A).  Following the shot on March 31, 2021, symptoms began on April 1, 2021 at 3:00 a.m.  I experienced more severe body aches, a fever of 102.5 degrees F, chills, a severe headache and severe dizziness.  The fever, chills, and severe headache subsided within 24-36 hours, with intermittent residual low grade fevers and dizziness for the next 3-5 days.  I also experienced what I would refer to as "brain fog" in that I felt like I was struggling to do certain tasks or concentrate.  Within two weeks of the second dosage, I noticed that I was experiencing joint pain throughout my body, even in joints that I never injured or had problems with in the past.  For three months, I was suffering from cyclical bouts of joint pain.  The pain was also accompanied with a low grade fever (between 100.5 and 101.5 degrees F).  The joint pain would last, but the fevers would subside within 24 hours.  These symptoms lasted through July 2021.  Eventually the fevers stopped, but the joint pain became progressively worse.  I sought medical attention with a Rheumatologist in September 2021.   I responded initially to an oral steroid.  OTC pain and/or anti-inflammatory medications did not work or reduce inflammation.  I had blood and urine testing as noted in section 19.  Dr. also prescribed Sulfasalazine, but I did not have any symptomatic improvement.  I'm currenlty on another round of oral steroids and I recently started Hydroxychloroquine.  Most of my labs were normal; however, my ANA Titer was 1:1280 and I recently tested positive for with a 1.8 for Chromatin Antibody.  Dr. has diagnosed me with Undifferentiated Connective Tissue Disease.  My lab work is consistant with Lupus, but my symptoms are more indicative of Rhematory Arthritis.   It is imporant to note that on September 22, 2021, my Chromatin Antibody test came back normal.  However, I was retested on January 31, 2022 and tested positive.  My ANA Titer was unchanged.    *See page 2 for continuation*
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Bacterial test negative, Bilirubin urine, Blood albumin normal, Blood alkaline phosphatase normal, Blood bilirubin normal
Clinical narrative: I initially experienced severe body aches, a headache, and a fever with the initial dosage given on March 2, 2021 at the same location noted above (Lot 027A21A).  Following the shot on March 31, 2021, symptoms began on April 1, 2021 at 3:00 a.m.  I experienced more severe body aches, a fever of 102.5 degrees F, chills, a severe headache and severe dizziness.  The fever, chills, and severe headache subsided within 24-36 hours, with intermittent residual low grade fevers and dizziness for the next 3-5 days.  I also experienced what I would refer to as "brain fog" in that I felt like I was struggling to do certain tasks or concentrate.  Within two weeks of the second dosage, I noticed that I was experiencing joint pain throughout my body, even in joints that I never injured or had problems with in the past.  For three months, I was suffering from cyclical bouts of joint pain.  The pain was also accompanied with a low grade fever (between 100.5 and 101.5 degrees F).  The joint pain would last, but the fevers would subside within 24 hours.  These symptoms lasted through July 2021.  Eventually the fevers stopped, but the joint pain became progressively worse.  I sought medical attention with a Rheumatologist in September 2021.   I responded initially to an oral steroid.  OTC pain and/or anti-inflammatory medications did not work or reduce inflammation.  I had blood and urine testing as noted in section 19.  Dr. also prescribed Sulfasalazine, but I did not have any symptomatic improvement.  I'm currenlty on another round of oral steroids and I recently started Hydroxychloroquine.  Most of my labs were normal; however, my ANA Titer was 1:1280 and I recently tested positive for with a 1.8 for Chromatin Antibody.  Dr. has diagnosed me with Undifferentiated Connective Tissue Disease.  My lab work is consistant with Lupus, but my symptoms are more indicative of Rhematory Arthritis.   It is imporant to note that on September 22, 2021, my Chromatin Antibody test came back normal.  However, I was retested on January 31, 2022 and tested positive.  My ANA Titer was unchanged.    *See page 2 for continuation*
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Blood calcium normal, Blood chloride normal, Blood creatine phosphokinase normal, Blood creatinine normal, Blood glucose normal
Clinical narrative: I initially experienced severe body aches, a headache, and a fever with the initial dosage given on March 2, 2021 at the same location noted above (Lot 027A21A).  Following the shot on March 31, 2021, symptoms began on April 1, 2021 at 3:00 a.m.  I experienced more severe body aches, a fever of 102.5 degrees F, chills, a severe headache and severe dizziness.  The fever, chills, and severe headache subsided within 24-36 hours, with intermittent residual low grade fevers and dizziness for the next 3-5 days.  I also experienced what I would refer to as "brain fog" in that I felt like I was struggling to do certain tasks or concentrate.  Within two weeks of the second dosage, I noticed that I was experiencing joint pain throughout my body, even in joints that I never injured or had problems with in the past.  For three months, I was suffering from cyclical bouts of joint pain.  The pain was also accompanied with a low grade fever (between 100.5 and 101.5 degrees F).  The joint pain would last, but the fevers would subside within 24 hours.  These symptoms lasted through July 2021.  Eventually the fevers stopped, but the joint pain became progressively worse.  I sought medical attention with a Rheumatologist in September 2021.   I responded initially to an oral steroid.  OTC pain and/or anti-inflammatory medications did not work or reduce inflammation.  I had blood and urine testing as noted in section 19.  Dr. also prescribed Sulfasalazine, but I did not have any symptomatic improvement.  I'm currenlty on another round of oral steroids and I recently started Hydroxychloroquine.  Most of my labs were normal; however, my ANA Titer was 1:1280 and I recently tested positive for with a 1.8 for Chromatin Antibody.  Dr. has diagnosed me with Undifferentiated Connective Tissue Disease.  My lab work is consistant with Lupus, but my symptoms are more indicative of Rhematory Arthritis.   It is imporant to note that on September 22, 2021, my Chromatin Antibody test came back normal.  However, I was retested on January 31, 2022 and tested positive.  My ANA Titer was unchanged.    *See page 2 for continuation*
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Blood immunoglobulin G, Blood potassium normal, Blood sodium normal, Blood test, Blood thyroid stimulating hormone
Clinical narrative: I initially experienced severe body aches, a headache, and a fever with the initial dosage given on March 2, 2021 at the same location noted above (Lot 027A21A).  Following the shot on March 31, 2021, symptoms began on April 1, 2021 at 3:00 a.m.  I experienced more severe body aches, a fever of 102.5 degrees F, chills, a severe headache and severe dizziness.  The fever, chills, and severe headache subsided within 24-36 hours, with intermittent residual low grade fevers and dizziness for the next 3-5 days.  I also experienced what I would refer to as "brain fog" in that I felt like I was struggling to do certain tasks or concentrate.  Within two weeks of the second dosage, I noticed that I was experiencing joint pain throughout my body, even in joints that I never injured or had problems with in the past.  For three months, I was suffering from cyclical bouts of joint pain.  The pain was also accompanied with a low grade fever (between 100.5 and 101.5 degrees F).  The joint pain would last, but the fevers would subside within 24 hours.  These symptoms lasted through July 2021.  Eventually the fevers stopped, but the joint pain became progressively worse.  I sought medical attention with a Rheumatologist in September 2021.   I responded initially to an oral steroid.  OTC pain and/or anti-inflammatory medications did not work or reduce inflammation.  I had blood and urine testing as noted in section 19.  Dr. also prescribed Sulfasalazine, but I did not have any symptomatic improvement.  I'm currenlty on another round of oral steroids and I recently started Hydroxychloroquine.  Most of my labs were normal; however, my ANA Titer was 1:1280 and I recently tested positive for with a 1.8 for Chromatin Antibody.  Dr. has diagnosed me with Undifferentiated Connective Tissue Disease.  My lab work is consistant with Lupus, but my symptoms are more indicative of Rhematory Arthritis.   It is imporant to note that on September 22, 2021, my Chromatin Antibody test came back normal.  However, I was retested on January 31, 2022 and tested positive.  My ANA Titer was unchanged.    *See page 2 for continuation*
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urea nitrogen/creatinine ratio, Blood urea normal, Blood urine absent, Borrelia test, C-reactive protein normal
Clinical narrative: I initially experienced severe body aches, a headache, and a fever with the initial dosage given on March 2, 2021 at the same location noted above (Lot 027A21A).  Following the shot on March 31, 2021, symptoms began on April 1, 2021 at 3:00 a.m.  I experienced more severe body aches, a fever of 102.5 degrees F, chills, a severe headache and severe dizziness.  The fever, chills, and severe headache subsided within 24-36 hours, with intermittent residual low grade fevers and dizziness for the next 3-5 days.  I also experienced what I would refer to as "brain fog" in that I felt like I was struggling to do certain tasks or concentrate.  Within two weeks of the second dosage, I noticed that I was experiencing joint pain throughout my body, even in joints that I never injured or had problems with in the past.  For three months, I was suffering from cyclical bouts of joint pain.  The pain was also accompanied with a low grade fever (between 100.5 and 101.5 degrees F).  The joint pain would last, but the fevers would subside within 24 hours.  These symptoms lasted through July 2021.  Eventually the fevers stopped, but the joint pain became progressively worse.  I sought medical attention with a Rheumatologist in September 2021.   I responded initially to an oral steroid.  OTC pain and/or anti-inflammatory medications did not work or reduce inflammation.  I had blood and urine testing as noted in section 19.  Dr. also prescribed Sulfasalazine, but I did not have any symptomatic improvement.  I'm currenlty on another round of oral steroids and I recently started Hydroxychloroquine.  Most of my labs were normal; however, my ANA Titer was 1:1280 and I recently tested positive for with a 1.8 for Chromatin Antibody.  Dr. has diagnosed me with Undifferentiated Connective Tissue Disease.  My lab work is consistant with Lupus, but my symptoms are more indicative of Rhematory Arthritis.   It is imporant to note that on September 22, 2021, my Chromatin Antibody test came back normal.  However, I was retested on January 31, 2022 and tested positive.  My ANA Titer was unchanged.    *See page 2 for continuation*
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Carbon dioxide normal, Chills, Chromaturia, Complement factor C3, Complement factor C4
Clinical narrative: I initially experienced severe body aches, a headache, and a fever with the initial dosage given on March 2, 2021 at the same location noted above (Lot 027A21A).  Following the shot on March 31, 2021, symptoms began on April 1, 2021 at 3:00 a.m.  I experienced more severe body aches, a fever of 102.5 degrees F, chills, a severe headache and severe dizziness.  The fever, chills, and severe headache subsided within 24-36 hours, with intermittent residual low grade fevers and dizziness for the next 3-5 days.  I also experienced what I would refer to as "brain fog" in that I felt like I was struggling to do certain tasks or concentrate.  Within two weeks of the second dosage, I noticed that I was experiencing joint pain throughout my body, even in joints that I never injured or had problems with in the past.  For three months, I was suffering from cyclical bouts of joint pain.  The pain was also accompanied with a low grade fever (between 100.5 and 101.5 degrees F).  The joint pain would last, but the fevers would subside within 24 hours.  These symptoms lasted through July 2021.  Eventually the fevers stopped, but the joint pain became progressively worse.  I sought medical attention with a Rheumatologist in September 2021.   I responded initially to an oral steroid.  OTC pain and/or anti-inflammatory medications did not work or reduce inflammation.  I had blood and urine testing as noted in section 19.  Dr. also prescribed Sulfasalazine, but I did not have any symptomatic improvement.  I'm currenlty on another round of oral steroids and I recently started Hydroxychloroquine.  Most of my labs were normal; however, my ANA Titer was 1:1280 and I recently tested positive for with a 1.8 for Chromatin Antibody.  Dr. has diagnosed me with Undifferentiated Connective Tissue Disease.  My lab work is consistant with Lupus, but my symptoms are more indicative of Rhematory Arthritis.   It is imporant to note that on September 22, 2021, my Chromatin Antibody test came back normal.  However, I was retested on January 31, 2022 and tested positive.  My ANA Titer was unchanged.    *See page 2 for continuation*
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Disturbance in attention, Dizziness, Double stranded DNA antibody, Feeling abnormal, Full blood count
Clinical narrative: I initially experienced severe body aches, a headache, and a fever with the initial dosage given on March 2, 2021 at the same location noted above (Lot 027A21A).  Following the shot on March 31, 2021, symptoms began on April 1, 2021 at 3:00 a.m.  I experienced more severe body aches, a fever of 102.5 degrees F, chills, a severe headache and severe dizziness.  The fever, chills, and severe headache subsided within 24-36 hours, with intermittent residual low grade fevers and dizziness for the next 3-5 days.  I also experienced what I would refer to as "brain fog" in that I felt like I was struggling to do certain tasks or concentrate.  Within two weeks of the second dosage, I noticed that I was experiencing joint pain throughout my body, even in joints that I never injured or had problems with in the past.  For three months, I was suffering from cyclical bouts of joint pain.  The pain was also accompanied with a low grade fever (between 100.5 and 101.5 degrees F).  The joint pain would last, but the fevers would subside within 24 hours.  These symptoms lasted through July 2021.  Eventually the fevers stopped, but the joint pain became progressively worse.  I sought medical attention with a Rheumatologist in September 2021.   I responded initially to an oral steroid.  OTC pain and/or anti-inflammatory medications did not work or reduce inflammation.  I had blood and urine testing as noted in section 19.  Dr. also prescribed Sulfasalazine, but I did not have any symptomatic improvement.  I'm currenlty on another round of oral steroids and I recently started Hydroxychloroquine.  Most of my labs were normal; however, my ANA Titer was 1:1280 and I recently tested positive for with a 1.8 for Chromatin Antibody.  Dr. has diagnosed me with Undifferentiated Connective Tissue Disease.  My lab work is consistant with Lupus, but my symptoms are more indicative of Rhematory Arthritis.   It is imporant to note that on September 22, 2021, my Chromatin Antibody test came back normal.  However, I was retested on January 31, 2022 and tested positive.  My ANA Titer was unchanged.    *See page 2 for continuation*